Home › Research › Long-term cohort studies
Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC
Anna E. Goodheart, Tess L. Brazier, Rong Ye, Patrick Stancu, Stephen N. Gomperts. Alzheimer s & Dementia, 2025-10-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Diagnosis of LBD had high specificity but low sensitivity, with fewer than half of autopsy-confirmed cases having received an LBD diagnosis. AD was the most common misdiagnosis. Participants diagnosed with AD were more likely to be female, to have a more amnestic phenotype, and to harbor a higher burden of AD co-pathology, and were less likely to have documented clinical features characteristic of LBD. These results highlight the need to improve LBD diagnosis in research and clinical settings, a need that emerging biomarkers may help address. HIGHLIGHTS: Less than half of cases with neocortical Lewy bodies were diagnosed with Lewy body dementia (LBD) Alzheimer's disease (AD) was the most common misdiagnosis Cases misdiagnosed were more likely to be female Cases diagnosed with AD presented with a more amnestic phenotype Cases diagnosed with AD had more AD co-pathology.
What this study adds
Evidence grade: Low
This study found that Lewy body dementia is often misdiagnosed as Alzheimer's disease, with fewer than half of autopsy-confirmed cases having received a Lewy body dementia diagnosis. It highlights the need to improve diagnosis, which may be helped by emerging biomarkers, but it does not test any treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Goodheart, A. E., Brazier, T. L., Ye, R., Stancu, P., & Gomperts, S. N. (2025). Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70794
Vancouver
Goodheart AE, Brazier TL, Ye R, Stancu P, Gomperts SN. Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70794. PMID: 41117431.
BibTeX
@article{goodheart2025-41117431,
author = {Goodheart, Anna E. and Brazier, Tess L. and Ye, Rong and Stancu, Patrick and Gomperts, Stephen N.},
title = {{Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70794},
pmid = {41117431},
url = {https://doi.org/10.1002/alz.70794}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Diagnosis of LBD had high specificity but low sensitivity, with fewer than half of autopsy-confirmed cases having received an LBD diagnosis.
- Participants diagnosed with AD were more likely to be female, to have a more amnestic phenotype, and to harbor a higher burden of AD co-pathology, and were less likely to have documented clinical features characteristic of LBD.
- These results highlight the need to improve LBD diagnosis in research and clinical settings, a need that emerging biomarkers may help address.
- HIGHLIGHTS: Less than half of cases with neocortical Lewy bodies were diagnosed with Lewy body dementia (LBD) Alzheimer's disease (AD) was the most common misdiagnosis Cases misdiagnosed were more likely to be female Cases diagnosed with AD presented with a more amnestic phenotype Cases diagnosed with AD had more AD co-pathology.
Why it matters
This study found that Lewy body dementia is often misdiagnosed as Alzheimer's disease, with fewer than half of autopsy-confirmed cases having received a Lewy body dementia diagnosis. It highlights the need to improve diagnosis, which may be helped by emerging biomarkers, but it does not test any treatment or cure.
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Stephen N. Gomperts: h-index 36 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41117431) |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Long-term cohort studies from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.